MCPHS​/Pfizer Global Clinical Supply PharmD Fellowship

Pfizer Inc., in conjunction with MCPHS, offers a unique two-year post-Pharm

D fellowship program in Global Clinical Supply (GCS) with a focus on Clinical Research Pharmacy.

This two-year fellowship program provides a comprehensive post-doctoral experience that fosters professional growth and develops the necessary skills for a successful career in Research and Development in the biopharmaceutical industry. During their first year, fellows will receive in-depth training in each of the following GCS disciplines and participate in rotational modules throughout other areas within the drug development process:

• Clinical Research Pharmacy
• Clinical Supply Informatics and Technology
• Global Clinical Supply Operations
• Clinical Supply Strategy and Management
• Quality Assurance

In their second year, fellows will engage in projects focused on optimizing and advancing the end-to-end physical and digital clinical supply chain. Throughout the fellowship, the Global Clinical Supply fellows will be integral members of Pfizer’s Global Clinical Supply organization. The fellows will have the opportunity to gain valuable experience in key functional areas that set and operationalize the clinical supply strategy, systems, packaging/labeling, logistics, as well as provide instructions and training of investigational products (IP) in compliance with Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) standards.

For over 175 years, Pfizer has delivered breakthrough medicines that change patients’ lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of global medicines in Oncology, Vaccines, Anti-Infectives, Inflammation and Immunology, as well as Internal Medicine and Hospital.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatment, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.

Please see our brochure for additional details.

The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis.

• Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
• Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
• All candidates must have authorization to work in the United States throughout the duration of the one- or two-year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).

The MCPHS application portal (SMApply) will open up on Monday, October 6, 2025
. Applicants must upload the following application materials to the online portal by Monday, November 3, 2025
:

• Letter of intent (addressed to the company specific program director/lead; found in each company brochure)
• Curriculum vitae
• Unofficial college transcript
• Contact information for three references. References will receive an electronic recommendation form to complete separately.

Three recommendation evaluation forms must be submitted no later than November 20, 2025 via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply.

Following a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore, candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.